Day: February 26, 2025

Orange County Transportation Authority awards contract for 50 zero-emission buses from NFI subsidiary New Flyer

Written by Customer Service on February 26, 2025. Posted in Public Companies.

ST. CLOUD, Minn., Feb. 26, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leading independent bus and coach manufacturer and a leader in zero-emission electric mass mobility solutions, subsidiary New Flyer of America Inc. (New Flyer), today announced a contract from the Orange County Transportation Authority (OCTA) for 50 New Flyer zero-emission buses. The order consists of 40 Xcelsior CHARGE FC™ 40-foot hydrogen fuel cell-electric buses and 10 Xcelsior CHARGE NG™ 40-foot battery-electric buses. The units were added to NFI’s Q4 2024 backlog and are supported by a combination of Federal Transit Administration (FTA) and local funding. OCTA plays a vital role in keeping Orange County moving, managing key transportation infrastructure for 3.2 million residents across 34 cities. The...

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

Written by Customer Service on February 26, 2025. Posted in Public Companies.

Conference call to be held Monday, March 3, 2025, at 8:30 AM ET NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held, Monday, March 3, 2025, at 8:30 AM ET to discuss results for the fourth quarter and full year 2024 and to provide a business outlook for 2025. Michael S. Weiss, Chairman and Chief Executive Officer, will host the call. In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics Earnings Call. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company’s website at www.tgtherapeutics.com. An audio recording of the conference call will also be available for replay...

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024

Written by Customer Service on February 26, 2025. Posted in Earnings Releases And Operating Results.

Achieved record positive Adjusted EBITDA* of $20 million for FY2024 (net loss of $8.3 million), exceeding latest guidance of $17-19 millionAchieved record quarterly revenue of $25 million and annual revenue of $85.9 millionNew credit facilities’ favorable interest rates and amortization schedules free up approximately $19 million in cash in 2025In-licensed two new Ionis assets in Canada to drive long-term growthMONTREAL, Feb. 26, 2025 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care, today reported business highlights and financial results for the fourth quarter and full year of fiscal year 2024, ended November...

Amerigo Announces 2024 Results & Quarterly Dividend

Written by Customer Service on February 26, 2025. Posted in Earnings Releases And Operating Results.

2024 Net Income of $19.2 million Annual EBITDA1 of $68.8 million and Free Cash Flow to Equity1 of $27.8 million 14th Quarterly Dividend of Cdn$0.03 Declared $21.2 million Returned to Shareholders in 2024 VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce financial results for the year and three months (“Q4-2024”) ended December 31, 2024. Dollar amounts in this news release are in U.S. dollars unless indicated otherwise. Amerigo’s annual financial results included annual net income of $19.2 million, earnings per share (“EPS”) of $0.12, EBITDA1 of $68.8 million and free cash flow to equity1 (“FCFE1”) of $27.8 million. In 2024, Amerigo returned $21.2 million to shareholders, including Cdn$.16 per share of quarterly and performance...

Verisk Reports Fourth-Quarter 2024 and Full-Year 2024 Financial Results

Written by Customer Service on February 26, 2025. Posted in Earnings Releases And Operating Results.

Consolidated revenues were $736 million, up 8.6% on a consolidated and an organic constant currency (OCC) basis for the fourth quarter of 2024. For the full year 2024, consolidated revenues were $2,882 million, up 7.5% and up 7.1% on an OCC basis. Income from continuing operations was $204 million, up 11.6% for the fourth quarter of 2024. Adjusted EBITDA, a non-GAAP measure, was $398 million, up 9.9%, and up 13.5% on an OCC basis. For the full year 2024, income from continuing operations was $951 million, up 23.7%, while adjusted EBITDA was $1,576 million, up 9.9%, on a consolidated and OCC basis. Diluted GAAP earnings per share from continuing operations (diluted EPS attributable to Verisk) were $1.44 for the fourth quarter of 2024, up 15.2%. Diluted adjusted earnings per share from continuing operations (diluted adjusted EPS), a non-GAAP...

Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC – 25 02 2025] – (CGWL)

Written by Customer Service on February 26, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LEARNING TECHNOLOGIES GROUP PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date...

Form 8.3 – [ALLIANCE PHARMA PLC – 25 02 2025] – (CGWL)

Written by Customer Service on February 26, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree ALLIANCE PHARMA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Avista Corp. Reports 2024 Results and Initiates 2025 Earnings Guidance

Written by Customer Service on February 26, 2025. Posted in Earnings Releases And Operating Results.

Consolidated earnings per diluted share of $2.29 for the full year of 2024 Initiated consolidated guidance of $2.52 to $2.72 per share for 2025SPOKANE, Wash., Feb. 26, 2025 (GLOBE NEWSWIRE) — Avista Corp. (NYSE: AVA) today announced financial results for 2024. Net income and earnings per diluted share for the fourth quarter and the year ended Dec. 31, 2024 compared to the same periods in 2023 are presented in the table below (dollars in millions, except per-share data): Fourth Quarter Year-to-Date 2024 2023 2024 2023 Net Income (Loss) by: Reportable Segments Avista Utilities $ 68 $ 83 $ 179 $ 167 AEL&P 3 3 8 9 Other non-reportable segment loss (4 ) (2 ) (7 ) (5 )Total net income $ 67 $ 84 $ 180 $ 171 Earnings...

Arhaus Reports Fourth Quarter and Full Year 2024 Financial Results

Written by Customer Service on February 26, 2025. Posted in Earnings Releases And Operating Results.

BOSTON HEIGHTS, Ohio, Feb. 26, 2025 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, reported fourth quarter and full year 2024 results for the period ended December 31, 2024. Highlights include:Net revenue was $347 million in the fourth quarter and $1,271 million for the full year of 2024. Gross margin decreased 1.8% to $139 million in the fourth quarter and decreased 7.3% to $501 million for the full year of 2024. Selling, general and administrative expenses increased 11.1% to $111 million in the fourth quarter and increased 10.5% to $415 million for the full year of 2024. Net and comprehensive income of $21 million in the fourth quarter and $69 million for the full year of 2024. Adjusted EBITDA was $41...

Taboola Reports Strong Fourth Quarter & Full Year 2024 Financial Results; Announces $200M Share Repurchase Expansion; Launches Realize Platform

Written by Customer Service on February 26, 2025. Posted in Earnings Releases And Operating Results.

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) — Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced its results for the fourth quarter and full year ended December 31, 2024. “2024 proved to be a transformative year for Taboola,” said Adam Singolda, CEO of Taboola. “Our team remained focused and dedicated, delivering the strong results we set out to achieve two years ago. This past year, we learned that advertisers are looking for more—and we’re ready to deliver. Today, we’re excited to announce our expansion into all performance advertising with the launch of Realize, our new independent performance platform that goes beyond search and social. Our investments in 2025 will enable Realize to increasingly empower our advertisers to achieve their desired outcomes at scale, using our...

Day: February 26, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals